Back to Directory
Interferon Beta-1b
Performance & EnduranceInterferon for multiple sclerosis, first interferon approved for MS.
Key Benefits
- ✓Reduces MS relapses
- ✓First MS disease-modifying drug
- ✓Slows disability progression
- ✓Established efficacy
Dosing Information
Dosage Range
250 mcg
Frequency
Every other day
Typical Duration
Ongoing
Detailed Protocol
Administered via subcutaneous injection every other day. Premedication recommended to reduce flu-like symptoms. Prescription required for MS patients.
About Interferon Beta-1b
Interferon beta-1b (Betaseron, Extavia) is a modified interferon beta produced in bacteria (vs mammalian cells for 1a). First disease-modifying therapy approved for MS. Reduces relapse rate in relapsing-remitting MS.
Research Notes
FDA-approved in 1993, first disease-modifying MS therapy. Historic importance. Still used though newer agents often preferred. Requires regular lab monitoring.
Potential Side Effects
- •Flu-like symptoms very common
- •Injection site necrosis possible
- •Depression
- •Liver enzyme elevations
- •Lymphopenia
- •Requires monitoring
Always consult with a healthcare professional before starting any peptide therapy.